Max Mitchell

November 10, 2015 | The Legal Intelligencer

The plaintiff in a civil clergy sex-abuse case has settled his claims against the Archdiocese of Philadelphia and the three men who allegedly abused him.

By Max Mitchell

4 minute read

November 10, 2015 | The Legal Intelligencer

A Philadelphia jury has awarded $1.75 million to a plaintiff who alleged that taking the antipsychotic drug Risperdal caused gynecomastia, a condition in which boys grow excessive breast tissue.

By Max Mitchell

3 minute read

November 10, 2015 | The Legal Intelligencer

The recent Pennsylvania Supreme Court election not only changed the partisan makeup of the state's high court, but political observers say it likely changed the course for future state judicial elections.

By Lizzy McLellan and Max Mitchell

5 minute read

November 10, 2015 | The Legal Intelligencer

The recent Pennsylvania Supreme Court election not only changed the partisan makeup of the state's high court, but political observers say it likely changed the course for future state judicial elections.

By Lizzy McLellan 
and Max Mitchell

5 minute read

November 09, 2015 | The Legal Intelligencer

The plaintiff in a civil clergy sex-abuse case has settled his claims against the Archdiocese of Philadelphia and the three men who allegedly abused him.

By Max Mitchell

4 minute read

November 09, 2015 | The Legal Intelligencer

A Philadelphia jury has awarded $1.75 million to a plaintiff who alleged that taking the antipsychotic drug Risperdal caused gynecomastia, a condition in which boys grow excessive breast tissue.

By Max Mitchell

3 minute read

November 09, 2015 | The Legal Intelligencer

The recent Pennsylvania Supreme Court election not only changed the partisan makeup of the state's high court, but political observers say it likely changed the course for future state judicial elections.

By Lizzy McLellan 
and Max Mitchell

5 minute read

November 09, 2015 | The Legal Intelligencer

Janssen Pharmaceuticals is fighting to consolidate a novel Xarelto case into an existing mass-tort program in Philadelphia that, so far, has focused on claims the drug led to excessive bleeding.

By Max Mitchell

4 minute read

November 08, 2015 | The Legal Intelligencer

Janssen Pharmaceuticals is fighting to consolidate a novel Xarelto case into an existing mass-tort program in Philadelphia that, so far, has focused on claims the drug led to excessive bleeding.

By Max Mitchell

4 minute read

November 06, 2015 | The Legal Intelligencer

The recent Pennsylvania Supreme Court election not only changed the partisan makeup of the state's high court, but political observers say it likely changed the course for future state judicial elections.

By Lizzy McLellan and Max Mitchell

5 minute read